Showing results (221-230 of 255) with videos related to
Sort By:
Pageof 26
American Heart Journal|November 20, 2020
Oral anticoagulant use in patients with atrial fibrillation and mitral valve repairAshwin S Nathan, Lin Yang, Zhi Geng, et al.Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.American Heart Journal|November 29, 2024
Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare populationKriyana P Reddy, Kaitlyn Shultz, Lauren A Eberly, et al.The Journal of Thoracic and Cardiovascular Surgery|October 19, 2020
Essential information on surgical heart valve characteristics for optimal valve prosthesis selection: Expert consensus document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task ForceAndras P Durko, Philippe Pibarot, Pavan Atluri, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 6, 2020
Essential information on surgical heart valve characteristics for optimal valve prosthesis selection: expert consensus document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task ForceAndras P Durko, Philippe Pibarot, Pavan Atluri, et al.Circulation Research|December 25, 2013
Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction modelJohn W Macarthur, Jeffrey E Cohen, Jeremy R McGarvey, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 14, 2024
Deactivation of LVAD support for myocardial recovery-surgical perspectivesIan Nickel, Evgenij Potapov, Benjamin Sun, et al.JACC. Heart Failure|November 19, 2025
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 TrialJason N Katz, Jean M Connors, Francis D Pagani, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 11, 2019
Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task ForceAndras P Durko, Stuart J Head, Philippe Pibarot, et al.Journal of the American Heart Association|March 9, 2018
Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk ScoreEdo Y Birati, Thomas C Hanff, Dawn Maldonado, et al.Pageof 26